Cellular and differential genomic analysis of homologous recombination-deficient S-cerevisiae in response to cisplatin treatment

被引：0
|
作者：
Tartarian, Talar [1 ]
Fornsaglio, Jamie L. [1 ]
Ceryak, Susan [1 ]
Patierno, Steven R. [1 ]
O'Brien, Travis J. [1 ]
机构：
[1] George Washington Univ, Washington, DC USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3849
引用
收藏
页数：2
相关论文
共 35 条
  • [1] Endogenous base damage as a driver of genomic instability in homologous recombination-deficient cancers
    Aubuchon, Lindsey N.
    Verma, Priyanka
    DNA REPAIR, 2024, 141
  • [2] Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC
    Seiichi Imanishi
    Yasuto Naoi
    Kenzo Shimazu
    Masafumi Shimoda
    Naofumi Kagara
    Tomonori Tanei
    Tomohiro Miyake
    Seung Jin Kim
    Shinzaburo Noguchi
    Breast Cancer Research and Treatment, 2019, 174 : 627 - 637
  • [3] Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC
    Imanishi, Seiichi
    Naoi, Yasuto
    Shimazu, Kenzo
    Shimoda, Masafumi
    Kagara, Naofumi
    Tanei, Tomonori
    Miyake, Tomohiro
    Kim, Seung Jin
    Noguchi, Shinzaburo
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (03) : 627 - 637
  • [4] ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells
    Verma, Priyanka
    Zhou, Yeqiao
    Cao, Zhendong
    Deraska, Peter V.
    Deb, Moniher
    Arai, Eri
    Li, Weihua
    Shao, Yue
    Puentes, Laura
    Li, Yiwen
    Patankar, Sonali
    Mach, Robert H.
    Faryabi, Robert B.
    Shi, Junwei
    Greenberg, Roger A.
    NATURE CELL BIOLOGY, 2021, 23 (02) : 160 - +
  • [5] Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination-deficient cancer models
    Mehibel, Manal
    Xu, Yu
    Li, Caiyun G.
    Moon, Eui Jung
    Thakkar, Kaushik N.
    Diep, Anh N.
    Kim, Ryan K.
    Bloomstein, Joshua D.
    Xiao, Yiren
    Bacal, Julien
    Saldivar, Joshua C.
    Le, Quynh-Thu
    Cimprich, Karlene A.
    Rankin, Erinn B.
    Giaccia, Amato J.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (11):
  • [6] ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells
    Priyanka Verma
    Yeqiao Zhou
    Zhendong Cao
    Peter V. Deraska
    Moniher Deb
    Eri Arai
    Weihua Li
    Yue Shao
    Laura Puentes
    Yiwen Li
    Sonali Patankar
    Robert H. Mach
    Robert B. Faryabi
    Junwei Shi
    Roger A. Greenberg
    Nature Cell Biology, 2021, 23 : 160 - 171
  • [7] Functional Ex Vivo Assay to Select Homologous Recombination-Deficient Breast Tumors for PARP Inhibitor Treatment
    Naipal, Kishan A. T.
    Verkaik, Nicole S.
    Ameziane, Najim
    van Deurzen, Carolien H. M.
    ter Brugge, Petra
    Meijers, Matty
    Sieuwerts, Anieta M.
    Martens, John W.
    O'Connor, Mark J.
    Vrieling, Harry
    Hoeijmakers, Jan H. J.
    Jonkers, Jos
    Kanaar, Roland
    de Winter, Johan P.
    Vreeswijk, Maaike P.
    Jager, Agnes
    van Gent, Dik C.
    CLINICAL CANCER RESEARCH, 2014, 20 (18) : 4816 - 4826
  • [8] Genomic approaches for identifying DNA damage response pathways in S-cerevisiae
    Chang, Michael
    Parsons, Ainslie B.
    Sheikh, Bilal H.
    Boone, Charles
    Brown, Grant W.
    DNA REPAIR, PT B, 2006, 409 : 213 - 235
  • [9] POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STING signaling
    Oh, Grace
    Wang, Annie
    Wang, Lidong
    Li, Jiufeng
    Werba, Gregor
    Weissinger, Daniel
    Zhao, Ende
    Dhara, Surajit
    Hernandez, Rosmel E.
    Ackermann, Amanda
    Porcella, Sarina
    Kalfakakou, Despoina
    Dolgalev, Igor
    Kawaler, Emily
    Golan, Talia
    Welling, Theodore H.
    Sfeir, Agnel
    Simeone, Diane M.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (11):
  • [10] Discovery and Proof of Concept of Potent Dual Polθ/PARP Inhibitors for Efficient Treatment of Homologous Recombination-Deficient Tumors
    Ma, Luyu
    Chen, Wei
    Yang, Ming
    Ha, Si
    Xiong, Shuangshuang
    Zhu, Jiacheng
    Xiang, Hua
    Luo, Guoshun
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (05) : 3606 - 3625
1234